Furthermore, improvement of the inflammatory microenvironment may also contribute to VEGF upregulation: by lowering TNF-α and IL-6 levels, AF-SD likely alleviates inflammation-mediated suppression of angiogenesis, thus creating a permissive environment for VEGF-driven neovascularization [57]. This evidence concerns the gene TNF and atrial fibrillation.